200 Participants Needed

Psychotherapy for Caregiver Burden

Recruiting at 7 trial locations
WB
AA
TZ
Overseen ByTalia Zaider, PhD
Age: 18+
Sex: Any
Trial Phase: Phase 3
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial

Trial Summary

What is the purpose of this trial?

Participants will complete 1 set of questionnaires about 2 weeks before beginning their Meaning-Centered Psychotherapy for Caregivers/MCP-C or standard Supportive Psychotherapy for Caregivers/SP-C sessions. These questionnaires will ask about participants' sense of meaning and purpose in life, spiritual well-being, depression and/or anxiety, and social support. Participants will then be assigned to receive either MCP-C or SP-C for 7 sessions. Participants will complete additional sets of questionnaires about 2 weeks, 6 months, and 12 months after their last session of MCP-C or SP-C. It will take between 35 and 50 minutes to complete each set of questionnaires. After participants complete the MCP-C or SP-C sessions and all 4 sets of questionnaires, their participation in this study will end. If participants decide not to complete all 7 sessions, they may still choose to complete the questionnaires. Participants may remain in the study and continue to receive all 7 sessions of MCP-C or SP-C even if their loved one passes away.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you are currently engaged in regular individual psychotherapy, you may need to pause it during the trial.

What data supports the effectiveness of the treatment Meaning-Centered Psychotherapy for Caregivers (MCP-C)?

Research shows that Meaning-Centered Psychotherapy (MCP) helps improve psychological well-being and reduce distress in cancer patients, and MCP-C is being developed to help caregivers by addressing similar issues. A web-based version of MCP-C has been found to be feasible and acceptable, suggesting it could help caregivers find meaning and reduce their burden.12345

Is Meaning-Centered Psychotherapy safe for caregivers?

Meaning-Centered Psychotherapy, including its versions for caregivers, has been studied for its feasibility and acceptability, suggesting it is generally safe for use in humans.12356

How is Meaning-Centered Psychotherapy for Caregivers different from other treatments for caregiver burden?

Meaning-Centered Psychotherapy for Caregivers (MCP-C) is unique because it specifically targets existential distress, which is a common and critical element of caregiver burden, by helping caregivers find meaning and purpose in their role. Unlike other treatments, MCP-C is structured to address the spiritual and emotional well-being of caregivers, and it can be delivered flexibly, including through a web-based program.12357

Research Team

Talia I. Zaider, PhD - MSK Psychologist

Talia Zaider, PhD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Eligibility Criteria

This trial is for caregivers experiencing stress, burnout, or burden from caring for someone with cancer. Participants should be willing to undergo psychotherapy and complete several questionnaires before and after therapy sessions.

Inclusion Criteria

Residing in New York, New Jersey, or Florida, or have the ability to complete sessions while complying with current telehealth regulations
I am 18 years old or older.
I am caring for someone with advanced cancer.
See 2 more

Exclusion Criteria

I don't fully understand what participating in the study involves.
I am currently in ongoing therapy that I cannot pause.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2 weeks
1 visit (in-person)

Treatment

Participants receive either Meaning-Centered Psychotherapy for Caregivers (MCP-C) or Supportive Psychotherapy for Caregivers (SP-C) for 7 sessions

7 weeks
7 visits (in-person)

Follow-up

Participants complete additional sets of questionnaires about 2 weeks, 6 months, and 12 months after their last session to monitor maintenance of treatment gains

12 months
3 visits (virtual)

Treatment Details

Interventions

  • Meaning-Centered Psychotherapy for Caregivers
  • Supportive Psychotherapy for Caregivers
Trial OverviewThe study compares two types of therapy: Meaning-Centered Psychotherapy (MCP-C) and standard Supportive Psychotherapy (SP-C). Caregivers will be randomly assigned to one of these therapies for seven sessions, followed by evaluations over a year.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Meaning-Centered Psychotherapy for CaregiversExperimental Treatment1 Intervention
Meaning-Centered Psychotherapy for Caregivers/MCP-C
Group II: Supportive Psychotherapy for CaregiversActive Control1 Intervention
Supportive Psychotherapy for Caregivers/SP-C standard of care

Meaning-Centered Psychotherapy for Caregivers is already approved in United States for the following indications:

🇺🇸
Approved in United States as MCP-C for:
  • Support for caregivers of cancer patients

Find a Clinic Near You

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials
1,998
Recruited
602,000+

Findings from Research

A case study involving a patient with Glioblastoma Multiforme and his caregiver showed that concurrent engagement in Meaning-Centered Psychotherapy (MCP) and Meaning-Centered Psychotherapy for Caregivers (MCP-C) led to enhanced well-being for both individuals.
Both the patient and caregiver experienced increased connectedness and improved coping with existential distress, suggesting that simultaneous participation in these therapies may provide unique benefits that warrant further research.
The benefits of concurrent engagement in meaning-centered psychotherapy and meaning-centered psychotherapy for cancer caregivers: A case study.Roberts, KE., Applebaum, AJ.[2023]
Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C) is designed to address existential distress, a significant but often overlooked aspect of caregiver burden in those caring for patients with advanced cancer.
A case study from an initial MCP-C group revealed that participants experienced personal growth, improved self-care, and a deeper understanding of their caregiving experience, highlighting the potential benefits of this intervention.
Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C): Rationale and Overview.Applebaum, AJ., Kulikowski, JR., Breitbart, W.[2022]
The Care for the Cancer Caregiver (CCC) Workshop, a web-based adaptation of Meaning-Centered Psychotherapy, was found to be feasible and acceptable for cancer caregivers, with 84 participants randomized to either the workshop or a waitlist control.
While no significant differences were observed between groups in most measures, caregivers in the CCC Workshop showed significant increases in benefit finding, suggesting that the program may help enhance caregivers' sense of meaning and purpose over time.
Exploring the cancer caregiver's journey through web-based Meaning-Centered Psychotherapy.Applebaum, AJ., Buda, KL., Schofield, E., et al.[2021]

References

The benefits of concurrent engagement in meaning-centered psychotherapy and meaning-centered psychotherapy for cancer caregivers: A case study. [2023]
Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C): Rationale and Overview. [2022]
Exploring the cancer caregiver's journey through web-based Meaning-Centered Psychotherapy. [2021]
Cost-utility analysis of meaning-centered group psychotherapy for cancer survivors. [2019]
An adaptation of meaning-centered psychotherapy integrating "essential care": A pilot study. [2022]
Preliminary Findings on the Effectiveness of Meaning-Centered Psychotherapy in Patients with Pancreatobiliary Cancer. [2018]
Meaning-centered psychotherapy integrated with elements of compassion: A pilot study to assess feasibility and utility. [2019]